Course and Outcome

Schizophrenia: Third Edition

Volumn , Issue , 2011, Pages 104-141

  an der Heiden, Wolfram ^a   Häfner, Heinz ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Course types; Long term course; Medium ; Onset; Outcome; Quality of life; schizophrenia; Short ; Social course; Substance abuse; Suicide; Symptom dimensions

Indexed keywords

EID: 84879120976     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444327298.ch7     Document Type: Chapter

References (470)

1. Addington, J. & Addington, D. (1991) Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophrenia Research 5, 51-59.
2. Addington, J. & Addington, D. (1998) Effect of substance misuse in early psychosis. British Journal of Psychiatry 172 (Suppl. 33), 134-136.
3. Addington, J. & Addington, D. (2000) Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research 44, 47-56.
4. Addington, J., Young, J. & Addington, D. (2003) Social outcome in early psychosis. Psychological Medicine 33, 1119-1124.
5. Addington J., Van Mastrigt S., Addington D. (2004) Duration of untreated psychosis: impact on 2-year outcome. Psychological Medicine 34, 277-284.
6. Addington, J., Penn, D.L., Woods, S.W. et al. (2008) Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research 99, 119-124.
7. Albus, M., Hubmann, W., Ehrenberg, C. et al. (1996) Neuropsychological impairment in fi rst-episode and chronic schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience 246, 249-255.
8. Allardyce, J., McGreadie, R.G., Morrison, G. & van Os, J. (2007) Do symptom dimensions or categorial diagnosis best discriminate between known risk factors for psychosis? Social Psychiatry and Psychiatric Epidemiology 42, 429-437.
9. American Psychiatric Association (1994) DSM-IV: Diagnostic and Statistical Manual of Mental Disorders , 4th edn. Washington, DC: American Psychiatric Association.
10. an der Heiden, W. (1996) Der Langzeitverlauf der schizophrenen Psychosen-eine Literaturübersicht. Zeitschrift für Medizinische Psychologie 5, 8-21.
11. an der Heiden, W. & Krumm, B. (1991) The course of schizophrenia-some remarks on a yet unsolved problem of data collection. European Archives of Psychiatry and Clinical Neuroscience 240, 303-306.
12. an der Heiden, W., Krumm, B., Müller, S. et al. (1995) Mannheimer Langzeitstudie der Schizophrenie: Erste Ergebnisse zum Verlauf der Erkrankungüber 14 Jahre nach stationärer Erstbehandlung. Nervenarzt 66, 820-827.
13. an der Heiden, W., Krumm, B., Müller, S. et al. (1996) Eine prospektive Studie zum Langzeitverlauf schizophrener Psychosen: Ergebnisse der 14-Jahres-Katamnese. Zeitschrift für Medizinische Psychologie 5, 66-75.
14. an der Heiden, W., Könnecke, R., Maurer, K. et al. (2005) Depression in the long-term course of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 255, 174-184.
15. Andreasen, N.C. (1984) The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: University of Iowa.
16. Andreasen, N.C. (1989) The Scale for the Assessment of Negative Symptoms (SANS). British Journal of Psychiatry 155 (Suppl. 7), 53-58.
17. Andreasen, N.C. (1990) Positive and negative symptoms: historical and conceptual aspects. In: Andreasen, N.C., ed. Schizophrenia: Positive and Negative Symptoms and Syndromes Basel: Karger, pp. 1-42.
18. Andreasen, N.C. & Olsen, S.A. (1982) Negative vs. positive schizophrenia: defi nition and validation. Archives of General Psychiatry 39, 789-794.
19. Andreasen, N.C., Grove, W.M., Shapiro, R.W. et al. (1981) Reliability of lifetime diagnosis. Archives of General Psychiatry 38, 400-405.
20. Andreasson, S., Allebeck, P., Engstrom, A. & Rydberg U. (1987) Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet ii, 1483-1485.
21. Andreasen, N.C., Carpenter, W.T., Kane, J.M. et al. (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 162, 441-449.
22. Angermeyer, M.C. & Matschinger, H. (2000) Neuroleptika und Lebensqualität. Ergebnisse einer Patientenbefragung. Psychiatrische Praxis 27, 64-68.
23. Antonova, E., Sharma, T., Morris, R. & Kumari, V. (2004) The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophrenia Research 70, 117-145.
24. Arndt, S., Andreasen, N.C., Flaum, M. et al. (1995) A longitudinal study of symptom dimensions in schizophrenia-Prediction and patterns of change. Archives of General Psychiatry 52, 352-360.
25. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A. & Moffitt, T.E. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 325, 1212-1213.
26. Arseneault, L., Cannon, M., Witton, J. & Murray, R.M. (2004) Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 184, 110-117.
27. Arora, A., Avasthi, A. & Kulhara, P. (1997) Subsyndromes of chronic schizophrenia: a phenomenological study. Acta Psychiatrica Scandinavica 96, 225-229.
28. Ballon, J.S., Kaur, T., Marks, I.I. & Cadenhead, K.S. (2007) Social functioning in young people at risk for schizophrenia. Psychiatry Research 151, 29-35.
29. Barak, Y., Knobler, C.Y. & Aizenberg, D. (2004) Suicide attempts among elderly schizophrenic patients: a 10-year case-control study. Schizophrenia Research 71, 77-81.
30. Barnes, T.R.E., Hutton, S.B., Chapman, M.J. et al. (2000) West London fi rst-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. British Journal of Psychiatry 177, 207-211.
31. Barnes, T.R.E., Mutsatsa, S.H., Hutton, S.B., Watt, H.C. & Joyce, E.M. (2006) Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 188, 237-242.
32. Bartels, S.J., Drake, R.E. & McHugo, G.J. (1992) Alcohol abuse, depression, and suicidal behavior in schizophrenia. American Journal of Psychiatry 149, 394-395.
33. Baxter, D. & Appleby, L. (1999) Case register study of suicide risk in mental disorders. British Journal of Psychiatry 175, 322-326.
34. Bebbington, P.E., Craig, T., Garety, P. et al. (2006) Remission and relapse in psychosis: operational defi nitions based on case-note data. Psychological Medicine 36, 1551-1562.
35. Becker, T., Leese, M., Clarkson, P. et al. (1998) Links between social network and quality of life: an epidemiologically representative study of psychotic patients in south London. Social Psychiatry and Psychiatric Epidemiology 33, 229-304.
36. Bell, M.D. & Mishara, A.L. (2006) Does negative symptom change relate to neurocognitive change in schizophrenia? Schizophrenia Research 81, 17-27.
37. Bengtsson-Tops, A. & Hansson, L. (1999) Subjective quality of life in schizophrenic patients living in the community. Relationship to clinical and social characteristics. European Psychiatry 14, 256-263.
38. Biehl, H., Maurer, K., Schubart, C. et al. (1986) Prediction of outcome and utilization of medical services in a prospective study of fi rst onset schizophrenics. European Archives of Psychiatry and Neurological Sciences 236, 139-147.
39. Bilder, R.M. (1998) The neuropsychology of schizophrenia: what, when, where, how? In: Fleischhacker, V.W., Hinterhuber, H. & Meise, U., eds. Schizophrenie Störrungen: State of the Art II. Innsbruck: Vrelag Integrative Psychiatrie, pp. 155-171.
40. Bilder, R.M., Goldman, R.S., Robinson, D. et al. (2000) Neuropsychology of fi rst-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry 157, 549-559.
41. Bilder, R.M., Mukherjee, S., Rieder, R.O. & Pandurangi, A.K. (1985) Symptomatic and neuropsychological components of defect status. Schizophrenia Bulletin 11, 409-419.
42. Binder, J., Albus, M., Hubmann, W. et al. (1998) Neuropsychological impairment and psychopathology in fi rst-episode schizophrenic patients related to the early cousre of the illness. European Archives of Psychiatry and Clinical Neuroscience 248, 70-77.
43. Blanchard, J.J., Horan, W.P. & Collins, L.M. (2005) Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophrenia Research 77, 151-165.
44. Bland, R.C. & Orn, H. (1978) Fourteen-years outcome in early schizophrenia. Psychological Medicine 4, 244-254.
45. Bland, R.C., Parker, J.H. & Orn, H. (1976) Prognosis in schizophrenia. A ten-year follow-up of fi rst admissions. Archives of General Psychiatry 33, 949-954.
46. Bleuler, M. (1968) A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophenia. In: Rosenthal, D. & Kety, S.S., eds. The Transmission of Schizophrenia. Oxford: Pergamon Press, pp. 3-12.
47. Bleuler, M. (1972) Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken-und Familiengeschichten. Stuttgart: Thieme.
48. Bottlender, R., Strauss, A. & Möller, H.-J. (2000) Impact of duration of symptoms prior to fi rst hospilization on acute outcome in 998 schizophrenic patients. Schizophrenic Research 44, 145-150.
49. Bottlender, R., Sato, T., Jager, M. et al. (2003) The impact of the duration of untreated psychosis prior to fi rst psychiatric admission on the 15-year outcome in schizophrenia. Schizophrenia Research 62, 37-44.
50. Boydell, J., van Os, J., Caspi, A. et al. (2006) Trends in cannabis use prior to fi rst presentation with schizophrenia, in South-East London between 1965 and 1999. British Journal of Psychiatry 36, 1441-1446.
51. Bralet, M.C., Loas, G., Yon, V. & Mar é chal, V. (2002) Clinical characteristics and risk factors for Kraepelinian subtype of schizophrenia: replication of previous fi ndings and relation to summer birth. Psychiatry Research 111, 147-154.
52. Breier, A., Schreiber, J.L., Dyer, J. & Pickar, D. (1991) National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry 48, 239-246.
53. Brennan, P.A., Mednick, S.A. & Hodgins, S. (2000) Major mental disorders and criminal violence in a Danish birth cohort. Archives of General Psychiatry 57, 494-500.
54. Bressan, R.A., Chaves, A.C., Pilowsky, L.S. et al. (2003) Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Research 117, 47-56.
55. Brown, G.W. (1960) Length of hospital stay and schizophrenia: a review of statistical studies. Acta Psychiatrica et Neurologica Scandinavica 35, 414-430.
56. Brown, S. (1997) Excess mortality of schizophrenia. A meta-analysis. British Journal of Psychiatry 171, 502-508.
57. Browne, S., Clarke, M., Gervin, M. et al. (2000) Determinants of quality of life at fi rst presentation with schizophrenia. British Journal of Psychiatry 176, 173-176.
58. Buchanan, R.W. & Heinrichs, D.W. (1989) The Neurological Evaluation Scale (NES): a structured instrument for the evaluation of neurological signs in schizophrenia. Psychiatry Research 27, 335-350.
59. Buchanan R.W., Ball M.P., Weiner E. et al. (2005) Olanzapine treatment of residual positive and negative symptoms. American Journal of Psychiatry 162, 124-129.
60. Buchsbaum, M.S., Shihabuddin, L., Hazlett, E.A. et al. (2002) Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate. Schizophrenia Research 55, 25-40.
61. Buchsbaum, M.S., Shihabuddin, L., Brickman, A.M. et al. (2003) Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophrenia Research 64, 53-62.
62. Bühler, B., Hambrecht, M., Löffl er, W., an der Heiden, W. & Häfner, H. (2002) Precipitation and determination of the onset and course of schizophrenia by substance abuse: a retrospective and prospective study of 232 population-based fi rst illness episodes. Schizophrenia Research 54, 243-251.
63. Burns, T. (2007) Hospitalisation as an outcome measure in schizophrenia. British Journal of Psychiatry 191 (Suppl. 50), s37-s41.
64. Cahn, W., Hulshoff Pol, H.E., Bongers, M. et al. (2002) Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. British Journal of Psychiatry 43 (Suppl.), s66-72.
65. Caldwell, C.B. & Gottesman, I.I. (1990) Schizophrenics kill themselves too: a review of risk factors of suicide. Schizophrenia Bulletin 16, 571-589.
66. Campbell, A., Converse, R.E. & Rodgers, W.L. (1976) The Quality of American Life: Perception, Evaluations, and Satisfactions. New York: Russell Sage Foundation.
67. Cantor-Graae, E., Nordström, L.G. & McNeil, T.F. (2001) Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Research 48, 69-82.
68. Carlsson, R., Nyman, H., Ganse, G. & Cullberg, J. (2006) Neuropsychological functions predict 1-and 3-year outcome in fi rst-episode psychosis. Acta Psychiatrica Scandinavica 113, 102-111.
69. Caron, J., Mercier, C., Diaz, P. & Martin, A. (2005) Socio-demographic and clinical predictors of quality of life in patients with schizophrenia or schizo-affective disorder. Psychiatry Research 137, 203-213.
70. Carpenter, W.T. (2007) Commentary: Deconstructing and reconstructing illness syndromes associated with psychosis. World Psychiatry 6, 28-29.
71. Carpenter, W.T. & Kirkpatrick, B. (1988) The heterogeneity of the long-term course of schizophrenia. Schizophrenia Bulletin 14, 645-652.
72. Carpenter, W.T. & Strauss, J.S. (1991) The prediction of outcome in schizophrenia. IV: Eleven-year follow-up of the Washington IPSS cohort. Journal of Nervous and Mental Disease 179, 517-525.
73. Carpenter, W.T., Heinrichs, D.W. & Wagman, A.M.I. (1988) Defi cit and nondefi cit forms of schizophrenia: the concept. American Journal of Psychiatry 145, 578-583.
74. Carpenter, W.T., Buchanan, R.W., Kirkpatrick, B., Thaker, G. & Tamminga, C. (1991) Negative symptoms: a critique of current approaches. In: Marneros, N.C., Andreasen, N.C. & Tsuang, M.T., eds. Negative Versus Positive Schizophrenia. Berlin: Springer, pp. 126-133.
75. Caspi, A., Moffi tt, T.E., Cannon, M. et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biolological Psychiatry 57, 1117-1127.
76. Castle, D. (2000) Women and schizophrenia. In: Castle, D., McGrath, J. & Kulkarni, J., eds. Women and Schizophrenia. Cambridge: Cambridge University Press, pp. 19-33.
77. Castle, D.J. & Morgan, V. (2008) Epidemiology. In: Mueser, K.T. & Jeste, D.V., eds. Clinical Handbook of Schizophrenia. New York: Guilford Press, pp. 14-24.
78. Cechnicki, A. & Walczewski, K. (1999) Dynamic of positive and negative syndrome in schizophrenia-prospective study. In: López-Ibor, J., Sartorius, N., Gaebel, W. et al. , eds. Psychiatry on New Thresholds. Abstracts of the XI World Congress of Psychiatry, Hamburg, August 6-11, 1999.
79. Censits, D.M., Ragland, J.D., Gur, R.C. & Gur, R.E. (1997) Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophrenia Research 24, 289-298.
80. Chakos, M., Schobel, S.A., Gu, H. et al. (2005) Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. British Journal of Psychiatry 186, 26-31.
81. Chapman, L.J., Chapman, J.P. & Roulin, M.L. (1976) Scales for physical and social anhedonia. Journal of Abnormal Psychology 87, 374-407.
82. Chapman, L.J., Chapman, J.P., Kwapil, T.R. et al. (1994) Putatively psychosis-prone subjects 10 years later. Journal of Abnormal Psychology 103, 171-183.
83. Chen, C.-K. & Murray, R.M. (2004) How does drug abuse interact with familial and developmental factors in the etiology of schizophrenia? In: Keshavan, M.S., Kennedy, J. & Murray, R.M., eds. Neurodevelopment and Schizophrenia. Cambridge: Cambridge University Press, pp. 248-269.
84. Choquet, M. & Ledoux, S. (1994) Epid é miologie et adolescence. Confrontations psychiatriques 27, 287-309.
85. Ciompi, L. (1980) Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin 6, 606-618.
86. Ciompi, L. & Müller, C. (1976) Lebensweg und Alter der Schizophrenen. Berlin: Springer.
87. Clarke, M. & O'Callaghan, E. (2003) The value of fi rst-episodes studies in schizophrenia. In: Murray, R.M., Cannon, M., Jones, P. et al., eds. The Epidemiology of Schizophrenia. New York: Cambridge University Press, pp. 148-166.
88. Clarke, M., Whitty, P., Browne, S. et al. (2006) Suicidality in fi rst episode psychosis. Schizophrenia Research 86, 221-225.
89. Cornblatt, B., Obuchowski, M., Schnur, D.B. & O'Biran, J. (1998) Hillside study of risk and early detection in schizophrenia. British Journal of Psychiatry 172 (Suppl. 3), 26-32.
90. Craig, T.J. Sigel, C., Hopper, K., Lin, S. & Sartorius, N. (1997) Outcome in schizophrenia and related disorders compared between developing and developed countries: a recursive partitioning re-analysis of the WHO DOSMeD data. British Journal of Psychiatry 170, 229-233.
91. Craig, T.J., Bromet, E.J., Fennig, S. et al. (2000) Is there an association between duration of untreated psychosis and 24-month clinical outcome in a fi rst-admission series? American Journal of Psychiatry 157, 60-66.
92. Crow, T.J. (1980a) Discussion: positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry 137, 383-386.
93. Crow, T.J. (1980b) Molecular pathology of schizophrenia: more than one disease process. British Medical Journal 260, 66-68.
94. Crow, T.J. (1980c) Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry 137, 383-386.
95. Crow, T.J. (1985) The two-syndrome concept: Origins and current status. Schizophrenia Bulletin 11, 471-486.
96. Davidson, L. & McGlashan, T.H. (1997) The varied outcomes of schizophrenia. Canadian Journal of Psychiatry 42, 34-43.
97. Davidson, M., Reichenberg, A., Rabinowitz, J. et al. (1999) Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry 156, 1328-1335.
98. de Haan, L., van Der Gaag, M. & Wolthaus, J. (2000) Duration of untreated psychosis and the long-term course of schizophrenia. European Psychiatry 15, 264-267.
99. de Haan, L., Linszen, D.H., Lenior, M.E. et al. (2003) Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophrenia Bulletin 29, 341-348.
100. de Hert, M., McKenzie, K. & Peuskens, J. (2001) Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophrenia Research 47, 127-134.
101. de Hert, M., van Winkel, R., Wampers, M. et al. (2007) Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophrenia Research 92, 68-73.
102. Deister, A. & Marneros, A. (1993) Long-term stability of subtypes in schizophrenic disorders: a comparison of four diagnostic systems. European Archives of Psychiatry and Clinical Neuroscience 242, 184-190.
103. DeLisi, L.E., Sakuma, M., Tew, W. et al. (1997) Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research 74, 129-140.
104. Dikeos, D.G., Wickham, H., McDonald, C.D. et al. (2006) Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry 189, 346-353.
105. Dollfus, S., Everitt, B., Ribeyre, J.M. et al. (1996) Identifying subtypes of schizophrenia by cluster analyses. Schizophrenia Bulletin 22, 545-555.
106. Döpfner, M., Plück, J., Berner, W. et al. (1997) [Mental disturbances in children and adolescents in Germany. Results of a representative study:age,gender and rater effects, in German] Z Kinder Jugendpsychiatr Psychother 25, 218-233.
107. Drake, R.J., Haley, C.J., Akhtar, S. & Lewis S.W. (2000) Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry 177, 511-515.
108. Drake, R.J., Dunn, G., Tarrier, N., Haddock, G., Haley, C. & Lewis, S. (2003) The evolution of symptoms in the early course of non-affective psychosis. Schizophrenia Research 63, 171-179.
109. Dubertret, C., Bidard, I., Adès, J. & Gorwood, P. (2006) Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explaines by co-morbid addiction. Schizophrenia Research 86, 284-290.
110. Dunayevich, E., Sethuraman, G., Enerson, M., Taylor, C.C. & Lin, D. (2006) Characteristics of two alternative schizophrenia remission defi nitions: Relationship to clinical and quality of life outcomes. Schizophrenia Research 86, 300-308.
111. D'Souza, D.C., Sewell, R.A. & Ranganathan, M. (2009) Cannabis and psychosis/schizophrenia: human studies. European Archives of Psychiatry and Clinical Neuroscience 259, 413-431.
112. Eastvold, A.D., Heaton, R.K. & Cadenhead, K.S. (2007) Neurocognitive defi cits in the (putative) prodrome and fi rst episode of psychosis. Schizophrenia Research 93, 266-277.
113. Eaton, W.W. (1999) Evidence for universitality and uniformity of schizophrenia around the world: assessment and implications. In: Gattaz, W.F. & Häfner, H., eds. Search for the Causes of Schizophrenia, Vol. IV. Balance of the Century. Darmstadt: Steinkopff Verlag, pp. 21-33.
114. Eaton, W.W., Romanoski, A., Anthony, J.C. & Nestadt, G. (1991) Screening for psychosis in the general population with a self-report interview. Journal of Nervous and Mental Disease 179, 689-693.
115. Eaton, W.W., Mortensen, P.B., Herman, H. et al. (1992a) Long-term ciyrse if hospitalization for schizophrenia. I. Risk for rehospitalization. Schizophrenia Bulletin 18, 217-227.
116. Eaton, W.W., Bukjerm W., Haro, J.M. et al. (1992b) Long-term course of hospitalization for schizophrenia. II. Change with passage of time. Schizophrenia Bulletin 18, 229-241.
117. Eaton, W.W., Thara, R., Federman, B., Melton, B. & Liang, K.Y. (1995) Structure and course of positive and negative symptoms in schizophrenia. Archives of General Psychiatry 52, 217-134.
118. Emsley, R., Turner, H.J., Oosthuizen, P.P. & Carr, J. (2005) Neurological abnormalities in fi rst-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophrenia Research 75, 35-44.
119. Emsley, R., Rabinowitz, J., Medori, R. & Early Psychosis Global Working Group (2007) Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophrenia Research 89, 129-139.
120. Endicott, J., Spitzer, R.L., Fleiss, J.L. & Cohen, J. (1976) The Global Assessment Scale. A procedure for measurement overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766-771.
121. Engelhardt, D.M., Rosen, B., Feldman, J. et al. (1982) A 15-year followup of 646 schizophrenic outpatients. Schizophrenia Bulletin 8, 493-503.
122. Falkai, P., Tepest, R., Honer, W.G. et al. (2004) Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view. Psychiatry Research 132, 261-271.
123. Fannon, D., Chitnis, X. & Doku, V. (2000) Features of structural brain abnormality detected in fi rst-episode psychosis. American Journal of Psychiatry 157, 1829-1834.
124. Faris, R.E.L. & Dunham, H.W. (1939) Mental Disorders in Urban Areas: An Ecological Study of Schizophrenia and Other Psychosis. Chicago: University or Chicago Press.
125. Fenton, W.S. (2000) Depression, suicide, and suicide prevention in schizophrenia. Suicide & Life Threatening Behavior 30, 34-49.
126. Fenton, W.S. & McGlashan, T.H. (1991a) Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry 48, 969-977.
127. Fenton, W.S. & McGlashan, T.H. (1991b) Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Archives of General Psychiatry 48, 978-986.
128. Fenton, W.S., McGlashan, T., Victor, B.J. & Blyler, C.R. (1997) Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. American Journal of Psychiatry 154, 199-204.
129. Ferdinand, R.F., van der Ende, J., Bongers, I. et al. (2005) Cannabis-psychosis pathway independent of other types of psychopathology. Schizophrenia Research 79, 289-295.
130. Fergusson, D.M., Horwood, L.J. & Ridder, E.M. (2005) Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100, 354-366.
131. Fergusson, D.M., Poulton, R., Smith, P.F. & Boden, J.M. (2006) Cannabis and psychosis. British Medical Journal 332, 172-176.
132. French, P., Shryane, N., Bentall, R.P., Lewis, S.W. & Morrison, A.P. (2007) Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis. British Journal of Psychiatry 51 (Suppl), s82-87.
133. Friis, S., Larsen, T.K., Melle, I. et al. (2003) Methodological pitfalls in early detection studies-the NAPE lecture 2002. Acta Psychiatrica Scandinavica 107, 3-9.
134. Fuller, R., Nopoulos, P., Arndt, S. et al. (2002) Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. American Journal of Psychiatry 159, 1183-1189.
135. Gaebel, W. & Frommann, N. (2000) Long-term course in schizophrenia: concepts, methods and research strategies. Acta Psychiatrica Scandinavica 102 (Suppl. 407), 49-53.
136. Ganev, K. (2000) Long-term trends of symptoms and disability in schizophrenia and related disorders. Social Psychiatry and Psychiatric Epidemiology 35, 389-395.
137. Gattaz, W.F., Brunner, J., Schmidt, A. & Maras, A. (1995) Increased breakdown of membrane phospholipids in schizophrenia: implications for the hypofrontality hypothesis. In: Häfner, H. & Gattaz, W.F., eds. Search for the Causes of Schizphrenia , Vol. III. Berlin: Springer, pp. 215-226.
138. Geddes, J.R. & Kendell, R.E. (1995) Schizophrenic subjects with no history of admission to hospital. Psychological Medicine 25, 859-868.
139. Giron, M. & Gomez-Beneyto, M. (2004) Relationship between family attitudes and social functioning in schizophrenia: a nine-month follow-up prospective study in Spain. Journal of Nervous and Mental Disease 192, 414-420.
140. Gold, A., Arndt, S., Nopoulos, P. et al. (1999) Longitudinal study of cognitive function in fi rst-episode and recent-onset schizophrenia. American Journal of Psychiatry 156, 1342-1348.
141. Goldacre, M., Shiwach, R. & Yeates, D. (1994) Estimating incidence and prevalence of treated psychiatric disorders from routine statistics: the example of schizophrenia in Oxfordshire. Journal of Epidemiology and Community Health 48, 318-322.
142. Goldberg, T.E., Hyde, T.M., Kleinman, J.E. & Weinberger, D.R. (1993) Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophrenia Bulletin 19, 797-804.
143. Goldberg, T.E., David, A. & Gold J.M. (2003) Neurocognitive defi cits in schizophrenia. In: Hirsch, S.R. & Weinberger, D.W., eds. Schizophrenia , 2nd edn. Oxford: Blackwell Publishing, pp. 168-184.
144. Gourzis, P., Katrivanou, A. & Beratis, S. (2002) Symptomatology of the initial prodromal phase in schizophrenia. Schizophrenia Bulletin 28, 415-429.
145. Gottesman, I.I., McGuffi n, P. & Farmer, A.E. (1987) Clinical genetics as clue to the "real" genetics of schizophrenia (a decade of modest gains while playing for a time). Schizophrenia Bulletin 13, 23-47.
146. Green, M.F. (1996) What are the functional consequences of neurocognitive defi cits in schizophrenia. American Journal of Psychiatry 153, 321-330.
147. Green, B., Young, R. & Kavanagh, D. (2005) Cannabis use and misuse prevalence among people with psychosis. British Journal of Psychiatry 187, 306-313.
148. Grunebaum, M.F., Oquendo, M.A., Harkavy-Friedman, J.M. et al. (2001) Delusions and suicidality. American Journal of Psychiatry 158, 742-747.
149. Gupta, S., Andreasen, N.C., Arndt, S. et al. (1997) The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of fi rst episode patients. Schizophrenia Research 23, 1-13.
150. Haas, G.L. & Sweeney, J.A. (1992) Premorbid and onset features of fi rst-episode schizophrenia. Schizophrenia Bulletin 18, 373-386.
151. Haas, G., Gattatt, L.S. & Sweeney, J.A. (1998) Delay to fi rst antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. Journal of Psychiatric Research 32, 151-159.
152. Häfner, H. (1995) Epidemiology of schizophrenia. The disease model of schizophrenia in the light of current epidemiological knowledge. European Psychiatry 10, 228-236.
153. Häfner, H. (2003a) Gender differences in schizophrenia. Psychoneuroendocrinology 28, 17-54.
154. Häfner, H. (2003b) Prodrome, onset and early course of schizophrenia. In: Murray, R.M., Cannon, M., Jones, P. et al. , eds. The Epidemiology of Schizophrenia. New York: Cambridge University Press, pp. 124-147.
155. Häfner, H. (2008) Cannabis und Schizophrenie. Speech at the 26. Psychiatrietage Königslutter. Nov 20-21, 2008.
156. Königslutter. Häfner, H. & an der Heiden, W. (1982) Evaluation gemeindenaher Versorgung psychisch Kranker. Archiv für Psychiatrie und Nervenkrankheiten 232, 71-95.
157. Häfner, H. & an der Heiden, W. (1986) The contribution of European case registers to research on schizophrenia. Schizophrenia Bulletin 12, 26-51.
158. Häfner, H. & an der Heiden, W. (2003) Course and outcome of schizophrenia. In: Hirsch, S.R. & Weinberger, D.R., eds. Schizophrenia , 2nd edn. Oxford: Blackwell Publishing, pp. 101-141.
159. Häfner, H. & Kasper, S. (1982) Akute lebensbedrohliche Katatonie. Epidemiologische und klinische Befunde. Nervenarzt 53, 385-394.
160. Häfner, H. & Maurer, K. (2003) The prodromal phase of psychosis. In: Miller, T., ed. Early Intervention in Psychotic Disorder. Amsterdam: Kluwer Academic Publishers, pp. 71-100.
161. Häfner, H. & Maurer, K. (2006) Early Detection of Schizophrenia: current evidence and future perspectives. World Psychiatry 5, 130-138.
162. Häfner, H. & Nowotny, B. (1995) Epidemiology of early-onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 245, 80-92.
163. Häfner, H., Riecher-Rössler, A., Hambrecht, M. et al. (1992) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research 6, 209-223.
164. Häfner, H., Maurer, K., Löffl er, W. et al. (1995) Onset and early course of schizophrenia. In: Häfner, H. & Gattaz, W.F., eds. Search for the Causes of Schizophrenia. Vol. III. Berlin: Springer, pp. 43-66.
165. Häfner, H., and der Heiden, W., Behrens, S. et al. (1998) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin 24, 99-113.
166. Häfner, H., Löffl er, W., Maurer, K. et al. (1999a) Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica 100, 105-118.
167. Häfner, H., Maurer, K., Löffl er, W. et al. (1999b) Onset and prodromal phase as determinants of the course. In: Gattaz, W.F. & Häfner, H., eds. Search for the Causes of Schizophrenia, Vol. IV: Balance of the Century. Darmstadt: Steinkopff, pp. 35-58.
168. Häfner, H., Löffl er, W., Riecher-Rössler, A. & Häfner-Ranabauer, W. (2001a) Schizophrenie und Wahn im höheren und hohen Lebensalter. Epidemiologie undätiologische Hypothesen. Nervenarzt 72, 347-357.
169. Häfner, H., Maurer, K., Löffl er, W. et al. (2001b) Onset and early course of schizophrenia-a challenge for early intervention. Psychiatrica Fennica 32 (Suppl. 2), 81-108.
170. Häfner, H., Maurer, K., Löffl er, W., an der Heiden, W., Könnecke, R. & Hambrecht, M. (2002) The early course of schizophrenia. In: Häfner, H., ed. Risk and protective factors in schizophrenia. Darmstadt: Steinkopff, pp. 207-228.
171. Häfner, H., Löffl er, W., Maurer, K. et al. (2003a) IRAOS Interview for the Retrospective Assessment of the Onset and Course of Schizophrenia and Other Psychoses. Göttingen: Hogrefe & Huber Publishers.
172. Häfner, H., Maurer, K., Löffl er, W. et al. (2003b) Modeling the early course of schizophrenia. Schizophrenia Bulletin 29, 325-340.
173. Häfner, H., Maurer, K., Trendler, G. et al. (2005) The early course of schizophrenia and depression. European Archives of Psychiatry and Clinical Neuroscience 255, 167-173.
174. Häfner, H., an der Heiden, W. & Maurer, K. (2008) Evidence for separate diseases? Stages of one disease or different combinations of symptom dimensions? European Archives of Psychiatry and Clinical Neuroscience 258 (Suppl. 2), 85-96.
175. Hambrecht, M. & Häfner, H. (1996) Substance abuse and the onset of schizophrenia. Biological Psychiatry 40, 1155-1163.
176. Hanssen, M., Bak, M., Bijl, R.V. et al. (2005) The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 44, 181-191.
177. Harding, C.M., Brooks, G.W., Ashikaga, T. et al. (1987a) The Vermont longitudinal study of persons with severe mental illness. I: Methodology, study sample, and overal status 32 years later. American Journal of Psychiatry 144, 718-726.
178. Harding, C.M., Brooks, G.W., Ashikaga, T. et al. (1987b) The Vermont longitudinal study of persons with severe mental illness. II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 144, 727-735.
179. Harrigan, S.M., McGorry, P.D. & Krstev, H. (2003) Does treatment delay in fi rst-episode psychosis really matter? Psychological Medicine 33, 97-110.
180. Harris, M.G., Henry, L.P., Harrigan, S.M. et al. (2005) The relationship between duration of untreated psychosis and outcome: An eight-year prospective study. Schizophrenia Research 79, 85-93.
181. Harrison, G., Croudace, T., Mason, P., Glazebrook, C. & Medley, I. (1996) Predicting the long-term outcome of schizophrenia. Psyclogical Medicine 26, 697-705.
182. Harrison, G., Hopper, K., Craig, T. et al. (2001) Recovery from psychotic illness: A 15 and 25 year international follow-up study. British Journal of Psychiatry 178, 506-517.
183. Harrison, P.J., Freemantle, N. & Geddes, J.R. (2003) Meta-analysis of brain weight in schizophrenia. Schizophrenia Research 64, 25-34.
184. Harrison, I., Joyce, E.M., Mutsatsa, S. et al. (2008) Naturalistic follow-up of co-morbid substance use in schizophrenia: The West London fi rst episode study. Psychological Medicine 38, 79-88.
185. Harrow, M. & Jobe, T.H. (2007) Factors involved in outcome and recovery in schizophrenic patients not on antipsychotic medications: a 15-year multifollow-up study. Journal of Nervous and Mental Disease 195, 406-414.
186. Harvey, P.D., Howanitz, E., Parrella, M., White, L. & Davidson, M. (1998) Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. American Journal of Psychiatry 155, 1080-1086.
187. Harvey, P.D., Parrella, M., White, L. et al. (1999) Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophrenia Research 35, 77-84.
188. Hawton, K., Sutton, L., Haw, C. et al. (2005) Schizophrenia and suicide: systematic review of risk factors. British Journal of Psychiatry 187, 9-20.
189. Healy, D., Harris, M., Tranter, R. et al. (2006) Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared. British Journal of Psychiatry 188, 223-228.
190. Heaton, R.K., Gladsjo, J.A., Palmer, B.W. et al. (2001) Stability and course of neuropsychological defi cits in schizophrenia. Archives of General Psychiatry 58, 24-32.
191. Hegarty, J.D., Baldessarini, R.J., Tohen, M. et al. (1994) One hundred years of schizophrenia: a meta-analysis of the outcome literature. American Journal of Psychiatry 151, 1409-1416.
192. Heil ä, H., Heikkinen, M.E., Isomets ä, E.T. et al. (1999a) Life events and completed suicide in schizophrenia: a comparison of suicide victims with and without schizophrenia. Schizophrenia Bulletin 25, 519-531.
193. Heil ä, H., Henriksson, M.M., Heikkinen, M.E. & Marttunen, M.J. (1999b) Suicide victims with schizophrenia in different treatment phases and adequacy of antipsychotic medication. Journal of Clinical Psychiatry 60, 200-208.
194. Heil ä, H., Haukka, J., Suvisaari, J. & Lönnqvist, J. (2005) Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychological Medicine 35, 725-732.
195. Heinrichs, R.W. & Zakzanis, K.K. (1998) Neurocognitive defi cit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426-445.
196. Heinrichs, R.W., Ruttan, L., Zakzanis, K.K. & Case, D. (1997) Parsing schizophrenia with neurocognitive tests: evidence of stability and validity. Brain and Cognition 35, 207-224.
197. Helldin, L., Kane, J.M., Karilampi, U. et al. (2007) Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophrenia Research 93, 160-168.
198. Henquet, C., Krabbendam, L., Spauwen, J. et al. (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330, 11.
199. Hides, L., Dawe, S., Kavanagh, D.J. & Young, R.M. (2006) Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. British Journal of Psychiatry 189, 137-143.
200. Ho, B.-C., Andreasen, N.C., Flaum, M. et al. (2000) Untreated initial psychosis: its relation to quality of life and symptom remission in fi rst-episode schizophrenia. American Journal of Psychiatry 157, 808-815.
201. Ho, B.-C., Alicata, D., Ward, J. et al. (2003a) Untreated initial psychosis: relation to cognitive defi cits and brain morphology in fi rst-episode schizophrenia. American Journal of Psychiatry 160, 142-148.
202. Ho, B.-C., Andreasen, N.C., Nopoulos, P. et al. (2003b) Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry 60, 585-594.
203. Hoff, A.L., Sakuma, M., Wieneke, M. et al. (1999) Longitudinal neuropsychological follow-up study of patients with fi rst-episode schizophrenia. American Journal of Psychiatry 156, 1336-1341.
204. Hoff, A.L., Sakuma, M., Razi, K. et al. (2000) Lack of association between duration of untreated illness and severity of cognitive and structural brain defi cits at the fi rst episode of schizophrenia. American Journal of Psychiatry 157, 1824-1828.
205. Holthausen, E.A., Wiersma, D., Sitskoorn, M.M. et al. (2002) Schizophrenic patients without neuropsychological defi cits: subgroup, disease severity or cognitive compensation? Psychiatry Research 112, 1-11.
206. Hopper, K., Harrison, G., Janca, A., & Sartorius, N. (2007) Recovery from Schizophrenia-An International Perspective. A Report from the WHO Collaborative Project, the International Study of Schizophrenia. Oxford: Oxford University Press.
207. Howard, R. & Jeste, D.V. (2003) Late-onset schizophrenia. In: Hirsch, S.R. & Weinberger, D.R., eds. Schizophrenia , 2nd edn. Oxford: Blackwell Publishing, pp. 68-79.
208. Huber, G., Gross, G. & Schüttler, R. (1979) Schizophrenie. Eine verlaufs-und sozialpsychiatrische Langzeitstudie. Berlin: Springer.
209. Huber, D., Henrich, G. & Herschbach, P. (1988) Measuring the quality of life: a comparison between physically and mentally chronically ill patients and healthy persons. Pharmacopsychiatria 21, 453-455.
210. Hughes, C., Kumari, V., Soni, W. e t al. (2002) Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophrenia Research 59, 137-146.
211. Hulshoff Pol, H.E., Schnack, H.G., Bertens, M.G.B. C. et al. (2002) Volume changes in gray matter in patients with schizophrenia. American Journal of Psychiatry 159, 244-250.
212. Huppert, J.D., Weiss, K.A., Lim, R., Pratt, S. & Smith, T.E. (2001) Quality of life in schizophrenia: contributions of anxiety and depression. Schizophrenia Research 51, 171-180.
213. Hwu, H.G., Chen, C.H., Hwang, T.J. et al. (2002) Symptom patterns and subgrouping of schizophrenic patients: signifi cance of negative symptoms assessed on admission. Schizophrenia Research 56, 105-119.
214. Isohanni, M., Isohanni, I., Järvelin, M.R. et al. (1999) Childhood and adolescent predictors of schizophrenia. In: López-Ibor, J., Sartorius, N, Gaebel, W. & Haasen, C., eds. Psychiatry on New Thresholds. Abstracts of the XI World Congress of Psychiatry, Hamburg, August 6-11, 1999.
215. Jablensky, A. (1995) Schizophrenia: the epidemiological horizon. In: Hirsch, S.R. & Weinberger, D.R., eds. Schizophrenia. Oxford: Blackwell Science, Ltd., pp. 206-252.
216. Jablensky, A. (2000) Symptome schizophrener Störungen. In: Helmchen, H., Henn, F., Lauter, H. et al. Psychiatrie der Gegenwart. Vol. 5 , 4th edn. Berlin: Springer, pp. 3-51.
217. Jablensky, A. (2003) The epidemiological horizon. In: Hirsch, S.R. & Weinberger, D.R., eds. Schizophrenia , 2nd edn. Oxford: Blackwell Publishing, pp. 203-231.
218. Jablensky, A., Schwarz, R. & Tomov, T. (1980) WHO collaborative study on impairments and disabilities associated with schizophrenic disorders. A preliminary communication: objectives and methods. Acta Psychiatrica Scandinavica (Suppl. 285), 152-163.
219. Jablensky, A., Sartorius, N., Ernberg, G. et al. (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten-Country Study. Psychological Medicine (Suppl. 20).
220. Jackson, J.H. (1887) Remarks on the evolution and dissolution of the nervous system. Journal of Mental Science 33, 25-48.
221. Jacobsen, L.K., Giedd, J.N., Castellanos, X. et al. (1998) Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. American Journal of Psychiatry 155, 678-685.
222. Jarskog, F., Gilmore, J.H., & Lieberman, J.A. (2004) Neurodegenerative models of schizophrenia. In: Keshavan, M., Kennedy, J. & Murray, R., eds. Neurodevelopment and Schizophrenia. Cambridge: Cambridge University Press, pp. 373-389.
223. Johnstone, E.C. (1991) Disabilities and circumstances of schizophrenic patients-a follow-up study. British Journal of Psychiatry 159 (Suppl.13).
224. Johnstone, E.C. (1999) Brain imaging and function: the balance of the century. In: Gattaz, W.F. & Häfner, H., eds. Search for the Causes of Schizophrenia , Vol. IV. Balance of the Century. Darmstadt: Steinkopff, pp. 293-305.
225. Johnstone, E.C., Lawrie, S.M. & Cosway, R. (2002) What does the Edinburgh high-risk study tell us about schizophrenia? American Journal of Medical Genetics (Neuropsychiatric Genetics) 114, 906-912.
226. Johnstone E.C., Ebmeier, K.P., Miller, P., Owens, D.G. & Lawrie, S.M. (2005) Predicting schizophrenia: fi ndings from the Edinburgh High-Risk Study. British Journal of Psychiatry 186, 18-25.
227. Jones, P.B. (1999) Longitudinal approaches to the search of the cause of schizophrenia: past, present and future. In: Gattaz, W.F. & Häfner, H., eds. Search for the Causes of Schizophrenia, Vol. IV. Balance of the Century. Darmstadt: Steinkopff Verlag, pp. 91-119.
228. Kane, J.M. & Lencz, T. (2008) Cognitive defi cits in schizophrenia: short-term and long-term. World Psychiatry 7, 29-30.
229. Kaplan, K.J. & Harrow, M. (1996) Positive and negative symptoms as risk factors for later suicidal activity in schizophrenics. Suicide & Life Threatening Behavior 26, 105-121.
230. Kavanagh, D.J., Waghorn, G., Jenner, L. et al. (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research 66, 115-124.
231. Kay, S.R. & Sevy, S. (1990) Pyramidical model of schizophrenia. Schizophrenia Bulletin 16, 537-545.
232. Kay, S.R., Fiszbein, A. & Opler, L.A. (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
233. Keefe, R.S.E. (2008) Should cognitive impairment be included in the diagnostic criteria for schizophrenia? World Psychiatry 7, 22-28.
234. Keefe, R.S., Mohs, R.C., Losonczy, M.F. et al. (1987) Characteristics of very poor outcome schizophrenia. American Journal of Psychiatry 144, 889-895.
235. Keefe, R.S., Frescka, E., Apter, S.H. et al. (1996) Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous fi ndings. American Journal of Psychiatry 153, 806-811.
236. Keller, M.B., Lavori, P.W., Friedman, B. et al. (1987) The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44, 540-548.
237. Keller, A., Castellanos, X., Vaituzis, C. et al. (2003) Progressive loss of cerebellar volume in childhood-onset schizophrenia. American Journal of Psychiatry 160, 128-133.
238. Kendler, K.S., Gallagher, T.J., Abelson, J.M. & Kessler, R.C. (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Archives of General Psychiatry 53, 1022-1031.
239. Keshavan, M.S., Diwadkar, V.A., Montrose, D.M. et al. (2005) Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophrenia Research 79, 57.
240. Kilzieh, N., Wood, A.E., Erdmann, J., Raskind, M. & Tapp, A. (2003) Depression in Kraepelinian schizophrenia. Comprehensive Psychiatry 44, 1-6.
241. Kirkpatrick, B. & Galderisi, S. (2008) Defi cit schizophrenia: an update. World Psychiatry 7, 143-147.
242. Kirkpatrick, B., Buchanan, R.W., McKenney, P.D., Alphs, L.D. & Carpenter, W.T. (1989) The Schedule for the Defi cit Syndrome: an instrument for research in schizophrenia. Psychiatry Research 30, 119-123.
243. Kohn, M. (1969) Class and Conformity: A Study of Values. Homewood, IL: Dorsey Press.
244. Kopelowicz, A., Liberman, R.P., Ventura, J. et al. (2005) Neurocognitive correlates of recovery from schizophrenia. Psychological Medicine 35, 1165-1173.
245. Krabbendam, L., Myin-Germeys, I., Hanssen, M. et al. (2005) Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. British Journal of Clinical Psychology 44, 113-125.
246. Kraepelin, E. (1893) Psychiatrie. Ein Lehrbuch für Studierende undärzte , 4 edn. Leipzig: Barth.
247. Kraepelin, E. (1920) Die Erscheinungsformen des Irreseins. Zeitschrift für die gesamte Neurologie und Psychiatrie 62, 1-29.
248. Krausz, M., Müller-Thomsen, T. & Haasen, C. (1995) Suicide among schizophrenic adolescents in the long-term course of illness. Psychopathology 28, 95-103.
249. Kristensen, K. & Cadenhead, K.S. (2007) Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research 151, 151-154.
250. Kurtz, M.M. (2005) Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophrenia Research 74, 15-26.
251. Lappin, J.M., Morgan, K.D., Morgan, C. et al. (2007) Duration of untreated psychosis and neuropsychological function in fi rst episode psychosis. Schizophrenia Research 95, 103-110.
252. Larsen, T.K., Friis, S., Haahr, U. et al. (2004) Premorbid adjustment in fi rst-episode non-affective psychosis: distinct patterns of pre-onset course. British Journal of Psychiatry 185, 108-115.
253. Larsen, T.K., Melle, I., Auestad, B. et al. (2006) Substance abuse in fi rst-episode non-affective psychosis. Schizophrenia Research 88, 55-62.
254. Lawrie, S.M. (2004) Premorbid structural abnormalities in schizophrenia. In: Keshavan, M., Kennedy, J. & Murray, R., eds. Neurodevelopment and Schizophrenia. Cambridge: Cambridge University Press, pp. 347-372.
255. Lawrie, S.M. & Abukmeil, S.S. (1998) Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. British Journal of Psychiatry 172, 110-120.
256. Lawrie, S.M., Whalley, H. & Kestelman, J.N. (1999) Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 353, 30-33.
257. Leff, J.P., Sartorius, N., Jablensky, A. et al. (1992) The International Pilot Study of Schizophrenia: fi ve-year follow-up fi ndings. Psychological Medicine 22, 131-145.
258. Lehman, A.F. (1996) Evaluating outcomes of treatments for persons with psychotic disorders. Journal of Clinical Psychiatry 57 (Suppl. 11), 61-67.
259. Lehman, A.F., Fischer, E.P., Postrado, L. et al. (2003) The Schizophrenia Care and Assessment Program Health Questionnaire (SCAP-HQ): an instrument to assess outcomes of schizophrenia care. Schizophrenia Bulletin 29, 247-256.
260. Lenzenweger, M.F., Dworkin, R.H. & Wethington, E. (1991) Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model. Schizophrenia Bulletin 17, 515-524.
261. Leon, C.A. (1989) Clinical course and outcome of schizophrenia in Cali, Colombia: a 10-year follow-up study. Journal of Nervous and Mental Disease 177, 593-606.
262. Leung, A. & Chue, P. (2000) Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica 401, 3-38.
263. Lewis, S.W. (1990) Computerised tomography in schizophrenia 15 years on. British Journal of Psychiatry 157 (Suppl. 9), 16-24.
264. Lewis, S., Tarrier, N., Haddock, G. et al. (2002) Randomized, controlled trial of cognitive-behaviour therapy in early schizophrenia: acute phase outcomes. British Journal of Psychiatry 181, 91-97.
265. Liddle, P.F. (1987a) Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine 17, 49-57.
266. Liddle, P.F. (1987b) The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. British Journal of Psychiatry 151, 145-151.
267. Liddle, P.F. (1994) Volition and schizophrenia in psychological medicine. In: David, A.S. & Cutting, J.C., eds. The Neuropsychology of Schizophrenia. Hove: Lawrence Erlbaum, pp. 39-49.
268. Liddle, P.F. & Barnes, T.R.E. (1990) Syndromes of chronic schizophrenia. British Journal of Psychiatry 157, 558-561.
269. Liberman, R.P. & Kopelowicz, A. (2005) Recovery from schizophrenia: a concept in search of research. Psychiatric Services 56, 735-742.
270. Liberman, R.P., Kopelowicz, A., Ventura, J. & Gutkind, D. (2002) Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry 14, 256-272.
271. Lieberman, J.A., Chakos, M., Wu, H. et al. (2001a) Longitudinal study of brain morphology in fi rst episode schizophrenia. Biological Psychiatry 49, 487-499.
272. Lieberman, J.A., Perkins, D., Belger, A. et al. (2001b) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biological Psychiatry 50, 884-897.
273. Limosin, F., Loze, J.-Y., Philippe, A. et al. (2007) Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophrenia Research 94, 23-28.
274. Lindenmayer, J.P., Brown, E., Baker, R.W. et al. (2004) An excitement subscale of the Positive and Negative Syndrome Scale. Schizophrenia Research 68, 331-337.
275. Link, B.G. & Dohrenwend, B.P. (1980) Formulation of hypotheses about the ratio of untreated to treated cases in the true prevalence studies of functional psychiatric disorders in adults in the United States. In: Dohrenwend, B.P., Dohrenwend, B.S., Schwartz, G.M. et al., eds. Mental Illness in the United States. Epidemiological Estimates. New York, Praeger, pp. 133-149.
276. Loebel, A.D., Lieberman, J.A., Alvir, J.M.J. et al. (1992) Duration of psychosis and outcome in fi rst-episode schizophrenia. American Journal of Psychiatry 149, 1183-1188.
277. Löffl er, W. & Häfner, H. (1999a) Dimensionen der schizophrenen Symptomatik-Vergleichende Modellprüfung an einem Erstepisodensample. Nervenarzt 70, 416-429.
278. Löffl er, W. & Häfner, H. (1999b) Ecological pattern of fi rst admitted schizophrenics in two German cities over 25 years. Social Science & Medicine 49, 93-108.
279. Loranger, A.W. (1990) The impact of DSM-III on diagnostic practice in a university hospital: a comparison of DSM-II and DSM-III in 10914 patients. Archives of General Psychiatry 47, 672-675.
280. Lorr, M., Klett, C.J. & McNair, D.M. (1963) Syndromes in Psychosis. New York: Pergamon Press.
281. Lukoff, D., Nuechterlein, K.H. & Ventura, J. (1986) Manual for Expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin 12, 594-602.
282. Maccabe, J.H., Aldouri, E., Fahy, T.A. et al. (2002) Do schizophrenic patients who managed to get to university have a non-developmental form of illness? Psychological Medicine 32, 535-544.
283. Maccoby, E.E. & Jacklin, C.N. (1980) Sex differences in aggression: a rejoinder and reprise. Child Development 51, 964-980.
284. Malla, A.K., Norman, R.M.G., McLean, T.S. et al. (2004) Determinants of quality of life in fi rst-episode psychosis. Acta Psychiatrica Scandinavica 109, 46-54.
285. Malla, A.K. & Payne, J. (2005) First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophrenia Bulletin 31, 650-671.
286. Malm, U., May, P.R.A. & Dencker, S.J. (1981) Evaluation of the quality of life of the schizophrenic outpatient: a checklist. Schizophrenia Bulletin 7, 477-487.
287. Malmberg, A., Lewis, G., David, A. & Allebeck, P. (1998) Premorbid adjustment and personality in people with schizophrenia. British Journal of Psychiatry 172, 308-313.
288. Marengo, J.T., Harrow, M., Sands, J. & Galloway, C. (1991) European versus U.S. data on the course on schizophrenia. American Journal of Psychiatry 148, 606-611.
289. Margolese, H.C., Malchy, L., Negrete, J.C. et al. (2004) Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 67, 157-166.
290. Margolese, H.C., Carlos Negrete, J., Tempier, R. & Gill, K. (2006) A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use. Schizophrenia Research 83, 65-75.
291. Marneros, A., Deister, A., & Rohde, A. (1991) Affektive, schizoaffektive und schizophrene Psychosen. Eine vergleichende Langzeitstudie. Berlin: Springer.
292. Marneros, A., Rohde, A. & Deister, A. (1995) Psychotic continuum under longitudinal considerations. In: Marneros, A., Andreasen, N.C. & Tsuang, M.T., eds. Psychotic Continuum. Berlin: Springer, pp. 17-30.
293. Marshall, M., Lewis, S., Lockwood, A. et al. (2005) Association between duration of untreated psychosis and outcome in cohorts of fi rst-episode patients. Archives of General Psychiatry 62, 975-983.
294. Mason, P., Harrison, G., Glazebrook, C., Medley, I., Dalkin, T. & Croudace, T. (1995) Characteristics of outcome in schizophrenia at 13 years. British Journal of Psychiatry 167, 596-603.
295. Mason, P., Harrison, G., Glazebrook, C. et al. (1996) The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization. British Journal of Psychiatry 169, 580-586.
296. Mathalon, D.H., Sullivan, E.V., Lim, K.O. & Pfefferbaum, A. (2001) Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Archives of General Psychiatry 58, 148-157.
297. Maurer, K. (1995) Der geschlechtsspezifi sche Verlauf der Schizophrenieüber 10 Jahre. Hamburg: Dr Kovac.
298. Maurer, K. & Häfner, H. (1991) Dependence, independence or interdependence of positive and negative symptoms. In: Marneros, A., Andreasen, N.C. & Tsuang, M.T., eds. Negative Versus Positive Schizophrenia. Berllin: Springer, pp. 160-182.
299. Maziade, M., Bouchard, S., Gingras, N. et al. (1996) Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II. Positive-negative distinction and childhood predictors of adult outcome. British Journal of Psychiatry 169, 371-378.
300. McCleery, A., Addington, J. & Addington, D. (2006) Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up. Schizophrenia Research 88, 187-191.
301. McGirr, A., Tousignant, M., Routhier, D. et al. (2006) Risk factors for completed suicide in schizophrenia and other chronic psy chotic disorders: a case-control study. Schizophrenia Research 84, 132-143.
302. McGlashan, T.H. (1984a) The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample. Archives of General Psychiatry 41, 573-585.
303. McGlashan, T.H. (1984b) The Chestnut Lodge follow-up study, II. LOng-term outcome of schizophrenia and the affective disorders. Archives of General Psychiatry 41, 586-601.
304. McGlashan, T.H. (1998) Early detection and intervention of schizophrenia: rationale and research. British Journal of Psychiatry 172 (Suppl. 33), 3-6.
305. McGlashan, T.H. (2006) Is active psychosis neurotoxic? Schizophrenia Bulletin 32, 609-613.
306. McGlashan, T.H. & Johannessen, J.O. (1996) Early detection and intervention with schizophrenia: rationale. Schizophrenia Bulletin 22, 201-222.
307. McGorry, P.D., McFarlane, C., Patton, G.C. et al. (1995) The prevalence of prodromal symptoms of schizophrenia in adolescence: a preliminary survey. Acta Psychiatrica Scandinavica 92, 241-249.
308. McGorry, P.D., Edwards, J., Mihalopoulos, C., Harrigan, S.M. & Jackson, H.J. (1996) EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin 22, 305-326.
309. McGorry, P.D., Yung, A.R., Phillips, L.J. et al. (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to fi rst episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921-928.
310. McGuffi n, P., Katz, R. & Aldrich, J. (1986) Past and Present State Examination: the assessment of lifetime ever psychopatholgy. Psychological Medicine 16, 461-465.
311. McGurk, S.R. & Mueser, K.T. (2003) Cognitive functioning and employment in severe mental illness. Journal of Nervous and Mental Diseases 191, 789-798.
312. McKenzie, K., van Os, J., Fahy, T. et al. (1995) Psychosis with good prognosis in Afro-Caribbean people now living in the United KOngdom. British Medical Journal 311, 1325-1327.
313. Mechanic, D., McAlpine, D., Rosenfi eld, S. & Davis, D. (1994) Effects of illness attribution and depression on the quality of life among persons with serious mental illness. Social Science & Medicine 39, 155-164.
314. Michaelos, A.L. (1980) Satisfaction and happiness. Social Indicators Research 8, 385-422.
315. Miles, C.P. (1977) Conditions predisposing to suicide: a review. Journal of Nervous and Mental Disease 164, 231-246.
316. Milev, P., Ho, B.-C., Arndt, S. & Andreasen, N.C. (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal fi rst-episode study with 7-Year follow-up. American Journal of Psychiatry 162, 495-506.
317. Miller, T.J., McGlashan, T.H. Woods, S.W. et al. (1999) Symptoms assessment in schizophrenic prodromal states. Psychiatric Quarterly 70, 273-287.
318. Mitelman, S.A., Shihabuddin, L., Brickman, A.M., Hazlett, E.A. & Buchsbaum, M.S. (2005) Volume of the cingulate and outcome in schizophrenia. Schizophrenia Research 72, 91-108.
319. Möller, H.-J. & von Zerssen, D. (1995) Course and outcome of schizophrenia. In: Hirsch, S.R. & Weinberger, D.R., eds. Schizophrenia. Oxford: Blackwell Science, Ltd., pp. 106-127.
320. Möller, H.-J., Schmid-Bode, W. & von Zerssen, D. (1986) Prediction of long-term outcome in schizophrenia by prognostic scales. Schizophrenia Bulletin 12, 225-235.
321. Möller, H.-J., von Zerssen, D., Werner-Eilert, K. & Wüschner-Stockheim, M. (1982) Outcome in schizophrenia and simlar paranoid psychosis. Schizophrenia Bulletin 8, 99-108.
322. Möller, H.-J., Scharl, W. & von Zerssen, D. (1984) Strauss-Carpenter-Skala:überprüfung ihres prognostischen Wertes für das 5-Jahres-' Outcome'schizophrener Patienten. European Archives of Psychiatry and Neurological Science 234, 112-117.
323. Möller, H.J., Bottlender, R., Grob, A. et al. (2002) The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophrenia Research 56, 87-94.
324. Morgan, C., Dazzan, P., Morgan, K. et al. (2006) First episode psychosis and ethnicity: initial fi ndings from the AESOP study. World Psychiatry 5, 40-46.
325. Müller, P., Guenther, U. & Lohmeyer, J. (1986) Behandlung und Verlauf schizophrener Psychosenüber ein Jahrzehnt. Nevenarzt 57, 332-341.
326. Murphy, H.B. & Raman, A.C. (1971) The chronicity of schizophrenia in indigenous tropical peoples. Results of a twelve-year follow-up survey in Mauritius. British Journal of Psychiatry 118, 489-497.
327. Murray, R.M. & Lewis, S.W. (1987) Is schizophrenia a neurodevelopmental disorder? British Medical Journal 295, 681-682.
328. Murray, R.M., Grech, A., Phillips, P. & Johnson, S. (2003) What is the relationship between substance abuse and schizophrenia? In: Murray, R.M., Jones, P.B., Susser, E. et al. , eds. The Epidemiology of Schizophrenia. Cambridge: Cambridge University Press, pp. 317-342.
329. Murray, V., McKee, I., Miller, P.M. et al. (2005) Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses. Psychological Medicine 35, 499-510.
330. Nair, T.R., Christensen, J.D., Kingsbury, S.J. et al. (1997) Progression of cerebrovascular enlargement and the subtyping of schizophrenia. Psychiatry Research 74, 141-150.
331. Nopoulos, P., Flashman, L., Flaum, M. et al. (1994) Stability of cognitive functioning early in the course of schizophrenia. Schizophrenia Research 14, 29-37.
332. Norman, R.M.G. & Malla, A.K. (2001) Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological Medicine 31, 381-400.
333. Norman, R.M.G., Townsend, L.A. & Malla, A.K. (2001) Duration of untreated psychosis and cognitive functioning in fi rst-episode patients. British Journal of Psychiatry 179, 340-345.
334. Norman R.M., Malla, A.K. & Manchanda, R. (2007) Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis. Schizophrenia Research 95, 111-114.
335. Nuechterlein, K.H. & Dawson, M.E. (1984) A heuristic vulnerability/stress model of schizophrenic episodes. Schizophrenia Bulletin 10, 300-312.
336. Nuechterlein, K.H., Miklowitz, D.J., Ventura, J. et al. (2006) Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples. Psychiatry Research 144, 153-166.
337. Ødegård, Ø. (1964) Patterns of discharge from Norwegian psychiatric hospitals before and after the introduction of psychotropic drugs. American Journal of Psychiatry 120, 772-778.
338. Ohta, Y., Nagata, K., Yoshitake, K. et al. (1990) Changes in negative symptoms of schizophrenic patients two years later. Japanese Journal of Psychiatry and Neurology 44, 521-529.
339. Oliver, J.P. & Mohamad, H. (1992) The quality of life of the chronically mentally ill: a comparison of public, private and voluntary residential provisions. British Journal of Social Work 22, 391-404.
340. Opjordsmoen, S. (1998) Delusional disorders. I. Comparative long-term outcome. Acta Psychiatrica Scandinavica 80, 603-612.
341. Osby, U., Correia, N., Brandt, L. et al. (2000) Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophrenia Research 45, 21-28.
342. Overall, J.E. & Gorham, D.R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports 10, 799-812.
343. Palmer, B.W., McClure, F.S. & Jeste, D.V. (2001) Schizophrenia in late life: fi ndings challenge traditional concepts. Harvard Review of Psychiatry 9, 51-58.
344. Pantelis, C., Barber, F.Z., Barnes, T.R., Nelson, H.E., Owen, A.M. & Robbins T.W. (1999) Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophrenia Research 37, 251-270.
345. Pantelis, C., Velakoulis, D., McGorry, P.D. et al. (2003) Neuroanatomical abnormalities befor and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361, 281-288.
346. Paulsen, J.S., Heaton, R.K., Sadek, J.R. et al. (1995) The nature of learning and memory impairments in schizophrenia. Journal of the International Neuropsychological Society 1, 88-99.
347. Peralta, V., de Leon, J. & Cuesta, M.J. (1992) Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. British Journal of Psychiatry 161, 335-343.
348. Peralta, V., Cuesta, M.J. & de Leon, J. (1994) An empirical analysis of latent structures underlying schizophrenic symptoms. Biological Psychiatry 36, 726-736.
349. Peralta, V., Cuesta, M.J., Giraldo, C. et al. (2002) Classifying psychotic disorders: issues regarding categorial vs. dimensional approaches and time frame to assess symptoms. European Archives of Psychiatry and Clinical Neuroscience 252, 12-18.
350. Perkins, D.O., Gu, H., Boteva, K. & Lieberman, J.A. (2005) Relationship between duration of untreated psychosis and outcome in fi rst-episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry 162, 1785-1804.
351. Perlstein, W.M., Carter, C.S., Noll, D.C. & Cohen, J.D. (2001) Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. American Journal of Psychiatry 158, 1105-1113.
352. Pietzcker, A. & Gaebel, W. (1983) Prediction of "natural" course, relapse and prophylactic response in schizophrenic patients. Pharmaco-psychiatria 16, 206-211.
353. Poulton, R., Caspi, A., Moffi tt, T.E. et al. (2000) Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of General Psychiatry 57, 1053-1058.
354. Priebe, S., Roeder-Wanner, U.U. & Kaiser, W. (2000) Quality of life in fi rst admitted schizophrenic patients: a follow-up study. Psychological Medicine 30, 225-230.
355. Putnam, K.M. & Harvey, P.D. (2000) Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophrenia Bulletin 26, 867-878.
356. Rabinowitz, J., Reichenberg, A., Weiser, M. et al. (2000) Cognitive and behavioural functioning in men with schizophrenia both before and shortly after fi rst admission to hospital. Cross-sectional analysis. British Journal of Psychiatry 177, 26-32.
357. Rakfeldt, J. & McGlashan, T.H. (1996) Onset, course, and outcome of schizophrenia. Current Opinion in Psychiatry 9, 73-76.
358. Ram, R., Bromet, E.J., Eaton, W.W., Pato, C. & Schwartz, J.E. (1992) The natural course of schizophrenia: a review of fi rst-admission studies. Schizophrenia Bulletin 18, 185-207.
359. Rapoport, J.L., Giedd, J.N., Blumenthal, J. et al. (1999) Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Archives of General Psychiatry 56, 649-654.
360. Ratakonda, S., Gorman, J.M., Yale, S.A. & Amador, X.F. (1998) Characterization of psychotic conditions. Use of the domains of psychopathology model. Archives of General Psychiatry 55, 75-81.
361. Rey, E.-R., Bailer, J., Bräuer, W. et al. (1994) Empirische Analysen zur Gültigkeit des Anhedonie-Konstruktes bei ersthospitalisierten Schizophrenen. Zeitschrift für Klinische Psychologie 23, 93-104.
362. Reynolds, J.R. (1858) On the pathology of convulsions, with special reference to those of children. Liverpool Medical and Chirurgical Journal 2, 1-14.
363. Riecher-Rössler, A. & Rössler, W. (1998) The course of schizophrenic psychoses: what do we really know? A selective review from an epidemiological perspective. European Archives of Psychiatry and Clinical Neuroscience 248, 189-202.
364. Robins, L.N. (1979) Longitudinal methods in the study of normal and pathological development. In: Kisker, K.P., Meyer, J.-E., Müller, C. et al., eds. Psychiatrie der Gegenwart. Forschung und Praxis. Grundlagen und Methoden der Psychiatrie, Bd.I. Berlin: Springer, pp. 627-684.
365. Robinson, D.G., Woerner, M.G., Alvir, J.M. et al. (1999a) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 156, 241-247.
366. Robinson, D.G., Woerner, M.G., Alvir, J.M. et al. (1999a) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 156, 544-549.
367. Rosen, J.L., Miller, T.J., D'Andrea, J.T. et al. (2006) Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophrenia Research 85, 124-131.
368. Rosenman, S., Korten, A., Medway, J. & Evans, M. (2003) Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatrica Scandinavica 107, 378-384.
369. Rothman, K.J. (2002) Epidemiology. Oxford: Oxford University Press.
370. Roy, M.-A., Merette, C. & Maziade, M. (2001) Subtyping schizophrenia according to outcome or severity: a search for homogeneous subgroups. Schizophrenia Bulletin 27, 115-138.
371. Rudnick, A. & Kravetz, S. (2001) The relation of social support-seeking to quality of life in schizophrenia. Journal of Nervous and Mental Disease 189, 258-262.
372. Rund, B.R. (1998) A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophrenia Bulletin 24, 425-435.
373. Rund, B.R., Landro, N.I. & Orbeck, A.L. (1997) Stability in cognitive dysfunctions in schizophrenic patients. Psychiatry Research 69, 131-141.
374. Rund, B.R., Melle, I., Friis, S. et al. (2007) The course of neurocognitive functioning in fi rst-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophrenia Research 91, 132-140.
375. Salokangas, R.K.R. (1997) Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytical study. Acta Psychiatrica Scandinavica 95, 32-39.
376. Salyers, M.P. & Mueser, K.T. (2001) Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research 48, 109-123.
377. Sartorius, N., Jablensky, A. & Shapiro, R.W. (1977) Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychological Medicine 7, 529-541.
378. Sartorius, N., Jablensky, A., Korten, A. et al. (1986) Early manifestation and fi rst-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychological Medicine 16, 909-928.
379. Sartorius, N., Jablensky, A., Ernberg, G. et al. (1987) Course of schizophrenia in different countries: some results of a WHO international comparative 5-year follow-up study. In: Häfner, H., Gattaz, W.F. & Janzarik, W., eds. Search for the causes of schizophrenia, Vol. I Berlin: Springer, pp. 107-113.
380. Sartorius, N., Gulbinat, W.H., Harrison, G., Laska, E. & Siegel, C. (1996) Long-term follow-up of schizophrenia in 16 countries: a description of the International Study of Schizophrenia conducted by the World Health Organization. Social Psychiatry and Psychiatric Epidemiology 31, 249-258.
381. Sato, T., Bottlender, R., Schröder, A. & Möller, H.-J. (2004) Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after fi rst-admission treatments. Schizophrenia Research 67, 175-183.
382. Saykin, A.J., Shtasel, D.L., Gur, R.E. et al. (1994) Neuropsychological defi cits in neuroleptic naive patients with fi rst-episode schizophrenia. Archives of General Psychiatry 51, 124-131.
383. Schreiber, H., Baur-Seack, K. & Kornhuber, H.H. (1999) Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging. Schizophrenia Research 40, 81-84.
384. Schubart, C., Schwarz, R., Krumm, B., & Biehl, H. (1986) Schizophrenie und soziale Anpassung. Berlin: Springer.
385. Schürhoff, F., Szöke, A., Bellivier, F. et al. (2003) Anhedonia in schizophrenia: a distinct familial subtype? Schizophrenia Research 61, 59-66.
386. Schürhoff, F., Golmard, J.-L., Szöke, A. et al. (2004) Admixture analysis of age at onset in schizophrenia. Schizophrenia Research 71, 35-41.
387. Scully, P.J., Coakley, G., Kinsella, A. & Waddington, J.L. (1997) Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in "static" v. "progressive" profi les. British Journal of Psychiatry 171, 154-158.
388. Seaton, B.E., Goldstein, G. & Allen, D.N. (2001) Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning. Neuropsychology Reviews 11, 45-67.
389. Selten, J.-P., Veen, N.D., Hoek, H.W. et al. (2007) Early course of schizophrenia in a representative Dutch incidence cohort. Schizophrenia Research 97, 79-87.
390. Shepherd, M., Watt, D., Falloon, I.R.H. & Smeeton, N. (1989) The natural history of schizophrenia: a fi ve-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychological Medicine (Suppl.15).
391. Silva, P.A. & Stanton, W.R. (1996) From Child to Adult: The Dunedin Multidisciplinary Health and Development Study. Auckland: Oxford University Press.
392. Simonsen, E., Friis, S., Haahr, U. et al. (2007) Clinical epidemiologic fi rst-episode psychosis: 1-year outcome and predictors. Acta Psychiatrica Scandinavica 116, 54-61.
393. Singh, S.P. (2007) Outcome measures in early psychosis. Relevance of duration of untreated psychosis. British Journal of Psychiatry 191 (Suppl. 50), s58-s63.
394. Skeate, A., Jackson, C., Birchwood, M. & Jones, C. (2002) Duration of untreated psychosis and pathways to care in fi rst-episode psychosis. Investigation of help-seeking behaviour in primary care. British Journal of Psychiatry 43 (Suppl.), s73-77.
395. Sobizack, N., Albus, M., Hubmann, W. et al. (1999) Neuropsychologische Defi zite bei ersterkrankten schizophrenen Patienten. Nervenarzt 70, 408-415.
396. Soyka, M., Albus, M., Kathmann, N. et al. (1993) Prevalence of alcohol and drug abuse in schizophrenic inpatients. European Archives of Psychiatry and Clinical Neuroscience 242, 362-372.
397. Spauwen, J., Krabbendam, L., Lieb, R., Wittchen, H.U. & van Os, J. (2003) Sex differences in psychosis: normal or pathological? Schizophrenia Research 62, 45-49.
398. Sponheim, S.R., Iacono, W.G., Thuras, P.D. & Beiser, M. (2001) Using biological indices to classify schizophrenia and other psychotic patients. Schizophrenia Research 50, 139-150.
399. Stahl, S.M. & Buckley, P.F. (2007) Negative symptoms and schizophrenia: a problem that will not go away. Acta Psychiatrica Scandinavica 115, 4-11.
400. Stephens, J.H., Ota, K.Y. & Carpenter, W.T. (1980) Diagnostic criteria for schizophrenia: Prognostic implications and diagnostic overlap. Psychiatry Research 2, 1-12.
401. Stirling, J., Lewis, S., Hopkins, R. & White, C. (2005) Cannabis use prior to fi rst onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research 75, 135-137.
402. Stoll, A.L. Hohen, M. Baldessarini, R.J. et al. (1993) Shifts in diagnositc frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-88. Americal Journal of Psychiatry 150, 1668-1673.
403. Strauss, J.S. & Carpenter, W.T. (1972) The prediction of outcome in schizophrenia. I. Characteristics of outcome. Archives of General Psychiatry 27, 739-746.
404. Strauss, J.S. & Carpenter, W.T. (1974) Characteristic symptoms and outcome in schizophrenia. Archives of General Psychiatry 30, 429-434.
405. Strauss, J.S. & Carpenter, W.T. (1977) The prediction of outcome in schizophrenia. II. Five-year outcome and its predictors. Archives of General Psychiatry 34, 159-163.
406. Sullivan, G., Wells, K.B. & Leake, B. (1992) Clinical factors associated with better quality of life in a seriously mentally ill population. Hospital and Community Psychiatry 43, 794-798.
407. Takei, N., Persaud, R., Woodruff, P. et al. (1998) First episodes of psychosis in Afro-Caribbean and White people. An 18-year follow-up population-based study. British Journal of Psychiatry 172, 147-153.
408. Talamo, A., Centorrino, F., Tondo, L. et al. (2006) Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophrenia Research 86, 251-255.
409. Tamminga, C.A., Buchanan, R.W. & Gold, J.M. (1998) The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology 13 (Suppl.), 21-26.
410. Tandon, R., DeQuardo, J.R., Taylor, S.F. et al. (2000) Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophrenia Research 45, 191-201.
411. Thara, R., Henrietta, M., Joseph, A. et al. (1994) Ten-year course of schizophrenia-the Madras longitudinal study. Acta Psychiatrica Scandinavica 90, 329-336.
412. The Scottish Schizophrenia Research Group (1992) The Scottish fi rst episode schizophrenia study. VIII. Five-year follow-up: clinical and psychosocial fi ndings. The Scottish Schizophrenia Research Group. British Journal of Psychiatry 161, 496-500.
413. Thornicroft, G. & Johnson, S. (1996) True versus treated prevalence of psychosis-The Prism Case Identifi cation Study. European Psychiatry 11 (Suppl. 4), 185.
414. Thorup, A., Petersen, L., Jeppesen, P. et al. (2007) Gender differences in young adults with fi rst-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. Journal of Nervous and Mental Disease 195, 396-405.
415. Tohen, M., Stoll, A.L., Strakowski, S.M. et al. (1992) The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophrenia Bulletin 18, 273-282.
416. Torrey, E.F. (2002) Studies of individuals with schizophrenia never treated with antipsychotic medications: a review. Schizophrenia Research 58, 101-115.
417. Toomey, R., Kremen, W.S., Simpson, J.C. et al. (1997) Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients. American Journal of Psychiatry 154, 371-377.
418. Usall, J., Haro, J.M., Ochoa, S., Márquez, M. & Araya, S. ; Needs of Patients with Schizophrenia group. (2002) Infl uence of gender on social outcome in schizophrenia. Acta Psychiatrica Scandinavica 106, 337-342.
419. van Os, J., Fahy, T.A., Jones, P. et al. (1996) Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychological Medicine 26, 161-176.
420. van Os, J., Gilvarry, C., Bale, R. et al. (1999) A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine 29, 595-606.
421. van Os, J., Hanssen, M., Bijl, R.V. & Ravelli, A. (2000) Strauss (1969) revisited: a psychosis continuum in the general population? Schizophrenia Research 45, 11-20.
422. van Os, J., Bak, M., Hanssen, M., Bijl, R.V., de Graaf, R. & Verdoux, H. (2002) Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319-327.
423. van Os, J., Drukker, M., Campo, J., Meijer, J., Bak, M. & Delespaul, P. (2006a) Validation of remission criteria for schizophrenia. American Journal of Psychiatry 163, 2000-2002.
424. van Os, J., Burns, T., Cavallaro, R. et al. (2006b) Standardized remission criteria in schizophrenia. Acta Psychiatrica Scandinavica 113, 91-95.
425. Varma, V.K., Malhotra, S. & Yao, E.S. (1996) Course and outcome of acute non-organic psychotic states. Indian Psychiatric Quarterly 67, 195-207.
426. Vazquez-Barquero, J.L., Cuesta-Nunez, M.J., de la Varga, M. et al. (1995) The Cantabria fi rst episode schizophrenia study: a summary of general fi ndings. Acta Psychiatrica Scandinavica 91, 156-162.
427. Veen, N.D., Selten, J.P., van der Tweel, I., Feller, W.G., Hoek, H.W. & Kahn, R.S. (2004) Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry 161, 501-506.
428. Velakoulis, D., Wood, S.J., Smith, D.J. et al. (2002) Increased duration of illness is associated with increased volume in right medial temporal/anterior cingulate grey matter in patients with chronic schizophrenia. Schizophrenia Research 57, 43-49.
429. Ventura, J., Nuechterlein, K.H., Green, M.F. et al. (2004) The timing of negative symptom exacerbation in relationship to positive symptom exacerbation in the early course of schjizophrenia. Schizophrenia Research 69, 333-342.
430. Verdoux, H., Maurice-Tison, S., Gay, B., van Os, J., Salamon, R. & Bourgeois, M.L. (1998) A survey of delusional ideation in primary-care patients. Psychological Medicine 28, 127-134.
431. Verdoux, H., Liraud, F., Bergey, C., Assens, F., Abalan, F. & van Os, J. (2001) Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of fi rst-admitted patients. Schizophrenia Research 49, 231-241.
432. Verdoux, H., Sorbara, F., Gindre, C. et al. (2002) Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophrenia Research 59, 77-84.
433. Vita, A., Dieci, M., Giobbio, G.M. et al. (1991) CT scan abnormalities and outcome of chronic schizophrenia. American Journal of Psychiatry 148, 1577-1579.
434. von Korff, M., Nestadt, G., Romanoski, A. et al. (1985) Prevalence of treated and untreated DSM-III schizophrenia. Results of a two-stage community survey. Journal of Nervous and Mental Disease 173, 577-581.
435. von Zerssen, D. & Hecht, H. (1987) Gesundheit, Glück, Zufriedenheit im Lichte einer katamnestischen Erhebung an psychiatrischen Patienten und gesunden Probanden. Psychotherapie und Medizinische Psychologie 37, 83-96.
436. Wade, D., Harrigan, S., Edwards, J. et al. (2006) Course of substance misuse and daily tobacco use in fi rst-episode psychosis. Schizophrenia Research 81, 145-150.
437. Waddington, J.L., Youssef, H.A. & Kinsella, A. (1995) Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine 25, 849-857.
438. Warner, R. (1985) Recovery from schizophrenia. Psychiatry and Political Economy. London: Routledge & Kegan Paul.
439. Watt, D.C., Katz, K. & Shepherd, M. (1983) The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychological Medicine 13, 663-670.
440. Weber, I. (1997) Die Lebenszufriedenheit einer Kohorte Schizophrener 15,5 Jahre nach stationärer Erstaufnahme. Doctoral dissertation, Fakultät für Klinische Medizin Mannheim der Ruprecht-Karls-Universität Heidelberg.
441. Weickert, T.W., Goldberg, T.E., Gold, J.M., Bigelow, L.B., Egan, M.F. & Weinberger D.R. (2000) Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry 57, 907-913.
442. Erratum in: 57, 1122. Weinberger, D.R. (1995) Schizophrenia as a neurodevelopmental disorder. In: Hirsch, S.R. & Weinberger, D.R., eds. Schizophrenia. Oxford: Blackwell, pp. 293-323.
443. Weinberger, D.R. & Berman, K.F. (1996) Prefrontal function in schizophrenia: confounds and controversies. Philosophical Transactions of the Royal Society London B Biological Science 351, 1495-503.
444. Welham, J., McLachlan, G., Davies, G. & McGrath, J. (2000) Heterogeneity in schizophrenia; mixture modelling of age-at-fi rst-admission, gender and diagnosis. Acta Psychiatrica Scandinavica 101, 312-317.
445. Wetherell, J.L., Palmer, B.W., Thorp, S.R., Patterson, T.L., Golshan, S. & Jeste, D.V. (2003) Quality of life in schizophrenia: contributions of anxiety and depression. Journal of Clinical Psychiatry 64, 1476-1482.
446. White, L., Harvey, P.D., Opler, L. & Lindenmayer, J.P. (1997) Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: a multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 30, 263-274.
447. Whiteford, H.A. & Peabody, C.A. (1989) The differential diagnosis of negative symptoms in chronic schizophrenia. Australian and New Zealand Journal of Psychiatry 23, 491-496.
448. Wing, J.K. & Brown, G.W. (1970) Institutionalism and Schizophrenia: A Comparative Study of THree Mental Hospitals 1960-1968. Cambridge: Cambridge University Press.
449. Wiersma, D., Giel, R., de Jong, A. et al. (1996) Assessment of the need for care 15 years after onset of a Dutch cohort of patients with schizophrenia, and an international comparison. Social Psychiatry and Psychiatric Epidemiology 31, 114-121.
450. Wiersma, D., Nienhuis, F.J., Slooff, C.J. & Giel, R. (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin 24, 75-85.
451. Wiersma, D., Wideerling, J., Dragonmirecka, E. et al. (2000) Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychological Medicine 30, 1155-1167.
452. Wig, N.N. & Parhee, R. (1989) Acute and transient psychoses: a view from the developing countries. In: Mezzich, J.E. & Cranach, M., eds. International Classifi cation in Psychiaty: Unity and Diversity. Cambridge: Cambridge University Press, pp. 115-121.
453. Wiles, N.J., Zammit, S., Bebbington, P. et al. (2006) Self-reported psychotic symptoms in the general population. British Journal of Psychiatry 188, 519-526.
454. Wilkinson, D.G. (1982) The suicide rate in schizophrenia. British Journal of Psychiatry 140, 138-141.
455. Wing, J.K. & Brown, G.W. (1970) Institutionalism and Schizophrenia. A Comparative Study of Three Mental Hospitals 1960 -1968. Cambridge: Cambridge University Press.
456. Wittchen, H.U., Höfl er, M., Lieb, R. et al. (2004) Depressive und psychotische Symptome in der Bevölkerung-eine prospektiv-longitudinale Studie (EDSP) an 2.500 Jugendlichen und jungen Erwachsenen (Abstract). Paper presented at the DGPPN Congress, Berlin, Nov. 24-27, 2004. Nervenarzt 75 (Suppl. 2), 87.
457. Wood, S.J., De Luca, C.R., Anderson, V., & Pantelis, C. (2004) Cognitive development in adolescence: cerebral underpinnings, neural trajectories, and the impact of abberations. In: Keshavan, M., Kennedy, J. & Murray, R., eds. Neurodevelopment and Schizophrenia Cambridge: Cambridge University Press, pp. 69-88.
458. Woods, B.T. (1998) Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. American Journal of Psychiatry 155, 1661-1670.
459. Woods, B.T., Ward, K.E. & Johnson, E.H. (2005) Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment. Schizophrenia Research 73, 221-228.
460. World Health Organization (1973) The International Pilot Study of Schizophrenia , Vol. 1. Geneva, WHO.
461. World Health Organization (1979) Schizophrenia. An International Follow-Up Study. New York: Wiley.
462. World Health Organization (1993) The ICD-10 classifi cation of mental and behavioural disorders: diagnostic criteria for research. Geneva: WHO.
463. World Health Organization (1998) The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Social Science and Medicine 46, 1569-1585.
464. Wunderink, L., Nienhuis, F.J., Sytema, S. & Wiersma, D. (2007) Predictive validity of proposed remission criteria in fi rst-episode schizophrenic patients responding to antipsychotics. Schizophrenia Bulletin 33, 792-796.
465. Wyatt, R.J. (1991) Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 17, 325-351.
466. Yung, A.R. (2006) Identifi cation of the population. In: Addington, J., Francey, S.M. & Morrison A.P. eds. Working with people at high risk of developing psychosis: a treatment handbook. Chichester-New York: John Wiley & Sons, pp. 7-24.
467. Yung, A.R. & McGorry, P.D. (1996) The prodromal phase of fi rst-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin 22, 353-370.
468. Yung, A.R., Phillips, L.J., McGorry, P.D. et al. (1998) Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry 172 (Suppl. 33), 14-20.
469. Yung, A.R., Phillips, L.J., Yuen, H.P. et al. (2003) Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research 60, 21-32.
470. Zimmerman, M., Coryell, W., Pfohl, B. & Stangl, D. (1988) The reliability of the Family History Method for psychiatric diagnosis. Archives of General Psychiatry 45, 320-322.